Alliance Medical Services of Pittsburgh - Ensign II

Alliance Medical Services of Pittsburgh - Ensign II, based in San Francisco, CA, is one of the SAMHSA-registered treatment programs operating in CA. The specific care levels offered by Alliance Medical Services of Pittsburgh - Ensign II should be confirmed directly with the admissions team. What this page can help with is the frame — what to ask, what to verify, what to compare against.

Care levels at Alliance Medical Services of Pittsburgh - Ensign II

On care levels specifically: Care-level specifics for Alliance Medical Services of Pittsburgh - Ensign II are not well-documented in the public SAMHSA record; a direct conversation with the admissions team is the reliable way to confirm what the facility actually provides. What that means in practice is that matching Alliance Medical Services of Pittsburgh - Ensign II to the right clinical situation depends on whether you or a loved one needs the level of care this facility actually offers — which is a clinician's judgment, not a facility's sales pitch.

Insurance and payment

On insurance specifically: Payment and insurance specifics for Alliance Medical Services of Pittsburgh - Ensign II are not fully documented in the SAMHSA registry — a direct admissions conversation is the reliable way to confirm what forms of payment are accepted and at what network-contract level. Before admission, ask the facility's utilization-review team for a written Verification of Benefits — not verbal assurance, which is where most post-treatment financial surprises come from. Also ask for specific plan-level confirmation, not carrier-level (e.g., "your Aetna PPO plan" not just "Aetna").

Before you call

The three questions that consistently separate programs worth considering from programs worth skipping: ASAM level of care match; written VOB for your plan; MAT policy. If the clinical situation involves opioid use disorder, confirm explicitly whether Alliance Medical Services of Pittsburgh - Ensign II offers medication-assisted treatment — buprenorphine, methadone, or naltrexone. Programs that do not are operating outside the current standard of care. Programs that cannot answer all three quickly are programs worth approaching with caution.